Heterogeneous T cell responses across Hepatitis B virus clinical phases revealed by rapid whole-blood HBV T cell analysis
Preprint
Abstract
Background & Aims Virus-specific T cells are crucial for controlling viral replication and disease progression in chronic hepatitis B (CHB). Nevertheless, due to the complexity of their analysis, CHB management relies exclusively on virological and biochemical markers. We aimed to develop a point-of-care immunological test, the HBV-cytokine release assay (HBV-CRA), designed to measure multiple cytokines in whole blood after HBV-peptide pool stimulation. Methods We first assessed the assay’s sensitivity by spiking whole blood with engineered HBV-specific T cells. Next, the performance of HBV-CRA was compared to ex vivo IFN-γ ELISpot assays in terms of sensitivity and consistency. We then applied the assay in a cross-sectional study of 235 CHB patients and longitudinally in acute HBV patients during HBsAg sero-clearance. Results The HBV-CRA detected cytokine secretion in response to peptide pools in approximately 80% of CHB patients. A profile of high IL-2 and IFN-γ after Core peptide stimulation was significantly associated with HBsAg clearance in acute HBV. The assay also revealed variability in cytokine levels and responses to different HBV proteins, even within the same clinical phase of CHB. Unsupervised clustering identified distinct HBV-specific immune patterns that did not segregate by clinical and virological categories. Notably, the assay revealed that NUC treatment impacted the functional profile of HBV-specific T cell responses. Conclusions The HBV-CRA is a rapid, easy-to-use assay that detects immune profiles linked to HBsAg clearance and distinguishes CHB patients based on antiviral T cell function. This capability to stratify patients within similar clinical phases offers a novel biomarker for host-viral interactions and could guide the selection of novel immunotherapies.Keywords
This publication has 41 references indexed in Scilit:
- Hepatitis B virus-specific CD4 T cell responses differentiate functional cure from chronic surface antigen+ infectionJournal of Hepatology, 2022
- TNF-α/IFN-γ profile of HBV-specific CD4 T cells is associated with liver damage and viral clearance in chronic HBV infectionJournal of Hepatology, 2020
- Comparative characterization of B cells specific for HBV nucleocapsid and envelope proteins in patients with chronic hepatitis BJournal of Hepatology, 2020
- Immunomodulatory Mechanism of Acyclic Nucleoside Phosphates in Treatment of Hepatitis B Virus InfectionHepatology, 2019
- Effector CD8+ T cell-derived interleukin-10 enhances acute liver immunopathologyJournal of Hepatology, 2017
- Redirecting T Cell Specificity Using T Cell Receptor Messenger RNA Electroporation2016
- Data-Driven Phenotypic Dissection of AML Reveals Progenitor-like Cells that Correlate with PrognosisCell, 2015
- TNF‐mediated inflammatory diseaseThe Journal of Pathology, 2007
- Analysis of antigen-specific T-cell responses with synthetic peptides—what kind of peptide for which purpose?Human Immunology, 2004
- Predominant T-helper 1 cytokine profile of hepatitis B virus nucleocapsid-specific T cells in acute self-limited hepatitis BHepatology, 1997